Titre : Cocancérogenèse

Cocancérogenèse : Questions médicales fréquentes

Termes MeSH sélectionnés :

Decision Trees
{ "@context": "https://schema.org", "@graph": [ { "@type": "MedicalWebPage", "name": "Cocancérogenèse : Questions médicales les plus fréquentes", "headline": "Cocancérogenèse : Comprendre les symptômes, diagnostics et traitements", "description": "Guide complet et accessible sur les Cocancérogenèse : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.", "datePublished": "2024-01-05", "dateModified": "2025-03-30", "inLanguage": "fr", "medicalAudience": [ { "@type": "MedicalAudience", "name": "Grand public", "audienceType": "Patient", "healthCondition": { "@type": "MedicalCondition", "name": "Cocancérogenèse" }, "suggestedMinAge": 18, "suggestedGender": "unisex" }, { "@type": "MedicalAudience", "name": "Médecins", "audienceType": "Physician", "geographicArea": { "@type": "AdministrativeArea", "name": "France" } }, { "@type": "MedicalAudience", "name": "Chercheurs", "audienceType": "Researcher", "geographicArea": { "@type": "AdministrativeArea", "name": "International" } } ], "reviewedBy": { "@type": "Person", "name": "Dr Olivier Menir", "jobTitle": "Expert en Médecine", "description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale", "url": "/static/pages/docteur-olivier-menir.html", "alumniOf": { "@type": "EducationalOrganization", "name": "Université Paris Descartes" } }, "isPartOf": { "@type": "MedicalWebPage", "name": "Carcinogenèse", "url": "https://questionsmedicales.fr/mesh/D063646", "about": { "@type": "MedicalCondition", "name": "Carcinogenèse", "code": { "@type": "MedicalCode", "code": "D063646", "codingSystem": "MeSH" }, "identifier": { "@type": "PropertyValue", "propertyID": "MeSH Tree", "value": "C23.550.727.098" } } }, "about": { "@type": "MedicalCondition", "name": "Cocancérogenèse", "alternateName": "Cocarcinogenesis", "code": { "@type": "MedicalCode", "code": "D003043", "codingSystem": "MeSH" } }, "citation": [ { "@type": "ScholarlyArticle", "name": "The Navigation of Mobile Robot in the Indoor Dynamic Unknown Environment Based on Decision Tree Algorithm.", "datePublished": "2022-06-20", "url": "https://questionsmedicales.fr/article/35769275", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1155/2022/3492175" } }, { "@type": "ScholarlyArticle", "name": "Novel decision tree models predict the overall survival of patients with submandibular gland cancer.", "datePublished": "2024-06-25", "url": "https://questionsmedicales.fr/article/38916666", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1007/s00784-024-05703-5" } }, { "@type": "ScholarlyArticle", "name": "A decision tree algorithm to identify predictors of post-stroke complex regional pain syndrome.", "datePublished": "2024-04-30", "url": "https://questionsmedicales.fr/article/38689114", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1038/s41598-024-60597-3" } }, { "@type": "ScholarlyArticle", "name": "A novel histopathological classification of implant periapical lesion: A systematic review and treatment decision tree.", "datePublished": "2022-12-22", "url": "https://questionsmedicales.fr/article/36548276", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1371/journal.pone.0277387" } }, { "@type": "ScholarlyArticle", "name": "Factors in the acquisition of independent walking in patients with cerebral infarction using decision tree analysis.", "datePublished": "2022-09-10", "url": "https://questionsmedicales.fr/article/36099658", "identifier": { "@type": "PropertyValue", "propertyID": "DOI", "value": "10.1016/j.jstrokecerebrovasdis.2022.106756" } } ], "breadcrumb": { "@type": "BreadcrumbList", "itemListElement": [ { "@type": "ListItem", "position": 1, "name": "questionsmedicales.fr", "item": "https://questionsmedicales.fr" }, { "@type": "ListItem", "position": 2, "name": "États, signes et symptômes pathologiques", "item": "https://questionsmedicales.fr/mesh/D013568" }, { "@type": "ListItem", "position": 3, "name": "Processus pathologiques", "item": "https://questionsmedicales.fr/mesh/D010335" }, { "@type": "ListItem", "position": 4, "name": "Processus néoplasiques", "item": "https://questionsmedicales.fr/mesh/D009385" }, { "@type": "ListItem", "position": 5, "name": "Carcinogenèse", "item": "https://questionsmedicales.fr/mesh/D063646" }, { "@type": "ListItem", "position": 6, "name": "Cocancérogenèse", "item": "https://questionsmedicales.fr/mesh/D003043" } ] } }, { "@type": "MedicalWebPage", "name": "Article complet : Cocancérogenèse - Questions et réponses", "headline": "Questions et réponses médicales fréquentes sur Cocancérogenèse", "description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.", "datePublished": "2025-05-13", "inLanguage": "fr", "hasPart": [ { "@type": "MedicalWebPage", "name": "Diagnostic", "headline": "Diagnostic sur Cocancérogenèse", "description": "Comment diagnostiquer la cocancérogenèse ?\nQuels tests sont utilisés pour évaluer la cocancérogenèse ?\nQuels signes cliniques peuvent indiquer une cocancérogenèse ?\nLa cocancérogenèse est-elle détectable par imagerie ?\nQuel rôle jouent les antécédents médicaux dans le diagnostic ?", "url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Decision+Trees&page=4#section-diagnostic" }, { "@type": "MedicalWebPage", "name": "Symptômes", "headline": "Symptômes sur Cocancérogenèse", "description": "Quels sont les symptômes associés à la cocancérogenèse ?\nLa cocancérogenèse provoque-t-elle des douleurs ?\nY a-t-il des symptômes spécifiques selon le type de cancer ?\nLes symptômes de cocancérogenèse sont-ils toujours visibles ?\nComment les symptômes évoluent-ils avec le temps ?", "url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Decision+Trees&page=4#section-symptômes" }, { "@type": "MedicalWebPage", "name": "Prévention", "headline": "Prévention sur Cocancérogenèse", "description": "Comment prévenir la cocancérogenèse ?\nLe dépistage précoce aide-t-il à prévenir la cocancérogenèse ?\nQuels aliments aident à prévenir la cocancérogenèse ?\nL'exercice physique joue-t-il un rôle dans la prévention ?\nLes vaccinations peuvent-elles prévenir la cocancérogenèse ?", "url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Decision+Trees&page=4#section-prévention" }, { "@type": "MedicalWebPage", "name": "Traitements", "headline": "Traitements sur Cocancérogenèse", "description": "Quels traitements sont disponibles pour la cocancérogenèse ?\nLa prévention est-elle un traitement pour la cocancérogenèse ?\nLes traitements varient-ils selon le type de cancer ?\nLa thérapie ciblée est-elle efficace contre la cocancérogenèse ?\nQuels sont les effets secondaires des traitements ?", "url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Decision+Trees&page=4#section-traitements" }, { "@type": "MedicalWebPage", "name": "Complications", "headline": "Complications sur Cocancérogenèse", "description": "Quelles complications peuvent survenir avec la cocancérogenèse ?\nLa cocancérogenèse peut-elle entraîner des complications respiratoires ?\nY a-t-il des complications liées aux traitements ?\nComment gérer les complications de la cocancérogenèse ?\nLes complications peuvent-elles affecter la qualité de vie ?", "url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Decision+Trees&page=4#section-complications" }, { "@type": "MedicalWebPage", "name": "Facteurs de risque", "headline": "Facteurs de risque sur Cocancérogenèse", "description": "Quels sont les principaux facteurs de risque de cocancérogenèse ?\nL'hérédité joue-t-elle un rôle dans la cocancérogenèse ?\nLes infections peuvent-elles être un facteur de risque ?\nLe mode de vie influence-t-il le risque de cocancérogenèse ?\nL'exposition à la radiation est-elle un facteur de risque ?", "url": "https://questionsmedicales.fr/mesh/D003043?mesh_terms=Decision+Trees&page=4#section-facteurs de risque" } ] }, { "@type": "FAQPage", "mainEntity": [ { "@type": "Question", "name": "Comment diagnostiquer la cocancérogenèse ?", "position": 1, "acceptedAnswer": { "@type": "Answer", "text": "Le diagnostic repose sur l'historique d'exposition et des tests biologiques spécifiques." } }, { "@type": "Question", "name": "Quels tests sont utilisés pour évaluer la cocancérogenèse ?", "position": 2, "acceptedAnswer": { "@type": "Answer", "text": "Des tests de dépistage, biopsies et analyses génétiques peuvent être utilisés." } }, { "@type": "Question", "name": "Quels signes cliniques peuvent indiquer une cocancérogenèse ?", "position": 3, "acceptedAnswer": { "@type": "Answer", "text": "Des symptômes comme des lésions cutanées ou des anomalies cellulaires peuvent apparaître." } }, { "@type": "Question", "name": "La cocancérogenèse est-elle détectable par imagerie ?", "position": 4, "acceptedAnswer": { "@type": "Answer", "text": "L'imagerie peut aider à visualiser des tumeurs, mais pas la cocancérogenèse elle-même." } }, { "@type": "Question", "name": "Quel rôle jouent les antécédents médicaux dans le diagnostic ?", "position": 5, "acceptedAnswer": { "@type": "Answer", "text": "Les antécédents d'exposition à des agents carcinogènes sont cruciaux pour le diagnostic." } }, { "@type": "Question", "name": "Quels sont les symptômes associés à la cocancérogenèse ?", "position": 6, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent inclure fatigue, douleurs inexpliquées et changements de peau." } }, { "@type": "Question", "name": "La cocancérogenèse provoque-t-elle des douleurs ?", "position": 7, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des douleurs peuvent survenir en raison de tumeurs ou d'inflammation associée." } }, { "@type": "Question", "name": "Y a-t-il des symptômes spécifiques selon le type de cancer ?", "position": 8, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les symptômes varient selon le type de cancer lié à la cocancérogenèse." } }, { "@type": "Question", "name": "Les symptômes de cocancérogenèse sont-ils toujours visibles ?", "position": 9, "acceptedAnswer": { "@type": "Answer", "text": "Non, certains symptômes peuvent être asymptomatiques et nécessitent un dépistage." } }, { "@type": "Question", "name": "Comment les symptômes évoluent-ils avec le temps ?", "position": 10, "acceptedAnswer": { "@type": "Answer", "text": "Les symptômes peuvent s'aggraver avec le temps si la cocancérogenèse progresse." } }, { "@type": "Question", "name": "Comment prévenir la cocancérogenèse ?", "position": 11, "acceptedAnswer": { "@type": "Answer", "text": "Éviter les agents carcinogènes et adopter un mode de vie sain sont essentiels." } }, { "@type": "Question", "name": "Le dépistage précoce aide-t-il à prévenir la cocancérogenèse ?", "position": 12, "acceptedAnswer": { "@type": "Answer", "text": "Oui, le dépistage précoce peut détecter des anomalies avant qu'elles ne deviennent cancéreuses." } }, { "@type": "Question", "name": "Quels aliments aident à prévenir la cocancérogenèse ?", "position": 13, "acceptedAnswer": { "@type": "Answer", "text": "Une alimentation riche en fruits, légumes et antioxydants peut réduire les risques." } }, { "@type": "Question", "name": "L'exercice physique joue-t-il un rôle dans la prévention ?", "position": 14, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exercice régulier peut diminuer le risque de développer des cancers." } }, { "@type": "Question", "name": "Les vaccinations peuvent-elles prévenir la cocancérogenèse ?", "position": 15, "acceptedAnswer": { "@type": "Answer", "text": "Certaines vaccinations, comme celles contre le HPV, peuvent réduire le risque de cancer." } }, { "@type": "Question", "name": "Quels traitements sont disponibles pour la cocancérogenèse ?", "position": 16, "acceptedAnswer": { "@type": "Answer", "text": "Les traitements incluent la chirurgie, la chimiothérapie et la radiothérapie." } }, { "@type": "Question", "name": "La prévention est-elle un traitement pour la cocancérogenèse ?", "position": 17, "acceptedAnswer": { "@type": "Answer", "text": "Oui, éviter les agents carcinogènes est une forme de traitement préventif." } }, { "@type": "Question", "name": "Les traitements varient-ils selon le type de cancer ?", "position": 18, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements sont adaptés en fonction du type de cancer et de son stade." } }, { "@type": "Question", "name": "La thérapie ciblée est-elle efficace contre la cocancérogenèse ?", "position": 19, "acceptedAnswer": { "@type": "Answer", "text": "Oui, la thérapie ciblée peut être efficace pour certains cancers liés à la cocancérogenèse." } }, { "@type": "Question", "name": "Quels sont les effets secondaires des traitements ?", "position": 20, "acceptedAnswer": { "@type": "Answer", "text": "Les effets secondaires peuvent inclure nausées, fatigue et immunosuppression." } }, { "@type": "Question", "name": "Quelles complications peuvent survenir avec la cocancérogenèse ?", "position": 21, "acceptedAnswer": { "@type": "Answer", "text": "Les complications incluent la progression du cancer et la métastase vers d'autres organes." } }, { "@type": "Question", "name": "La cocancérogenèse peut-elle entraîner des complications respiratoires ?", "position": 22, "acceptedAnswer": { "@type": "Answer", "text": "Oui, certains cancers peuvent affecter la fonction pulmonaire et causer des complications." } }, { "@type": "Question", "name": "Y a-t-il des complications liées aux traitements ?", "position": 23, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les traitements peuvent entraîner des complications comme l'infection ou l'anémie." } }, { "@type": "Question", "name": "Comment gérer les complications de la cocancérogenèse ?", "position": 24, "acceptedAnswer": { "@type": "Answer", "text": "La gestion implique un suivi médical régulier et des traitements symptomatiques." } }, { "@type": "Question", "name": "Les complications peuvent-elles affecter la qualité de vie ?", "position": 25, "acceptedAnswer": { "@type": "Answer", "text": "Oui, les complications peuvent significativement altérer la qualité de vie des patients." } }, { "@type": "Question", "name": "Quels sont les principaux facteurs de risque de cocancérogenèse ?", "position": 26, "acceptedAnswer": { "@type": "Answer", "text": "Les facteurs incluent le tabagisme, l'exposition à des produits chimiques et l'alcool." } }, { "@type": "Question", "name": "L'hérédité joue-t-elle un rôle dans la cocancérogenèse ?", "position": 27, "acceptedAnswer": { "@type": "Answer", "text": "Oui, des antécédents familiaux de cancer augmentent le risque de cocancérogenèse." } }, { "@type": "Question", "name": "Les infections peuvent-elles être un facteur de risque ?", "position": 28, "acceptedAnswer": { "@type": "Answer", "text": "Certaines infections, comme le HPV, sont des facteurs de risque connus pour le cancer." } }, { "@type": "Question", "name": "Le mode de vie influence-t-il le risque de cocancérogenèse ?", "position": 29, "acceptedAnswer": { "@type": "Answer", "text": "Oui, un mode de vie sédentaire et une mauvaise alimentation augmentent le risque." } }, { "@type": "Question", "name": "L'exposition à la radiation est-elle un facteur de risque ?", "position": 30, "acceptedAnswer": { "@type": "Answer", "text": "Oui, l'exposition à des radiations ionisantes est un facteur de risque pour certains cancers." } } ] } ] }

Sources (10000 au total)

Novel decision tree models predict the overall survival of patients with submandibular gland cancer.

While the accurate prediction of the overall survival (OS) in patients with submandibular gland cancer (SGC) is paramount for informed therapeutic planning, the development of reliable survival predic... We performed a retrospective cohort study using the Surveillance, Epidemiology and End Result (SEER) program. Demographic and peri-operative predictor variables were identified. The outcome variables ... A total of 1,705, 1,666, 1,543, and 1,413 SGC patients with a follow up of 12, 24, 60 and 120 months and exact survival status were identified from the SEER database. Predictor variables of age, sex, ... Based on the most important predictor variables identified using the large, SEER database, decision tree models were established that predict OS of SGC patients. The models offer a more exhaustive eva...

A novel histopathological classification of implant periapical lesion: A systematic review and treatment decision tree.

Implant periapical lesion (IPL), as a peri-implant disease originating from implant apex, maintains coronal osseointegration in the early stage. With the understanding to IPL increasingly deepened, IP... English articles on the topic of "implant periapical lesion", "retrograde peri-implantitis" and "apical peri-implantitis" were searched on PubMed, Embase and Web of Science from 1992 to 2021, and cita... The diversiform nature of IPL in the case reports confirms the need for such histopathological classification, which may enhance the comparison and management of different category....

Factors in the acquisition of independent walking in patients with cerebral infarction using decision tree analysis.

Independent walking is considered a rehabilitation factor for patients with stroke. There are no reports examining the predictors of independent walking at approximately one month after stroke onset. ... This retrospective, observational study was conducted on patients with cerebral infarction. The study period was from May 2017 to October 2021. Patients were categorized into independent (≥ 6; N=88) a... Overall, 186 participants (mean age, 77.8 ± 9.6 years; 104 men and 82 women) were included. The independent group had higher scores in Functional Assessment for Control of Trunk (14.7 ± 4.6 vs. 7.8 ± ... The interrelationship between trunk function, cognitive function, and balance function may influence the acquisition of independent walking in patients with stroke....

Cost-effectiveness of screening tools for identifying depression in early pregnancy: a decision tree model.

Although the effectiveness of screening tools for detecting depression in pregnancy has been investigated, there is limited evidence on the cost-effectiveness. This is vital in providing full informat... A decision tree was developed to model the identification and treatment pathways of depression from the first antenatal appointment to 3-months postpartum using the Whooley questions, the Edinburgh Po... In a 4-way comparison, the Whooley, EPDS and Whooley followed by the EPDS each had a similar probability of being cost-effective at around 30% for willingness to pay values from £20,000-30,000 per QAL... All three screening approaches tested had a higher probability of being cost-effective than the no-screen option. In the absence of a clear cost-effectiveness advantage for any one of the three screen... N/A....

Adding automated decision-tree models to multiparametric MRI for parotid tumours improves clinical performance.

Therapeutic management of parotid gland tumours depends on their histological type. To aid its characterisation, we sought to develop automated decision-tree models based on multiparametric magnetic r... 206 MRIs from 206 patients with histologically proven parotid gland tumours were included from January 2009 to January 2018. Multiparametric MRI findings (including parameters derived from diffusion-w... Compared to morphological sequences alone, the addition of multiparametric analysis significantly increased the diagnostic performance for all histological types (p < 0.001 to p = 0.011), except for l... The addition of decision tree prediction models based on multiparametric sequences improves the non-invasive diagnostic performance of parotid gland tumours. ADC and extracellular-extravascular space ...

Using a decision tree algorithm to distinguish between repeated supra-therapeutic and acute acetaminophen exposures.

This study aimed to compare clinical and laboratory characteristics of supra-therapeutic (RSTI) and acute acetaminophen exposures using a predictive decision tree (DT) algorithm.... We conducted a retrospective cohort study using the National Poison Data System (NPDS). All patients with RSTI acetaminophen exposure (n = 4,522) between January 2012 and December 2017 were included. ... The DT model had accuracy, precision, recall, and F1-scores of 0.75, respectively. Age was the most relevant variable in predicting the type of acetaminophen exposure, whether RSTI or acute. Serum ami... DT models can potentially aid in distinguishing between acute and RSTI of acetaminophen. Further validation is needed to assess the clinical utility of this model....